Skip to main content
Active Clinical Trials

Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma

By April 24, 2017No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 60

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective

Study ID Numbers: Master (No14)

Study First Received: October 11, 2014

Last Updated: June 8, 2016

Estimated Primary Completion Date: June 2016

 

Primary Outcome Measures:

response rate|progression free survival (PFS)|overall survival (OS)|estimation of treatment related toxicity

Sponsors and Collaborators:

Ain Shams University

Website Link: https://ClinicalTrials.gov/show/NCT02269878

Leave a Reply